ADM Q2 2025 slides: profits down 10%, company tightens full-year outlook

Archer-Daniels-Midland (ADM) reported a challenging Q2 2025, with adjusted EPS and total segment operating profit both declining 10% year-over-year, contributing to a 35% drop in H1 adjusted EPS and a trailing ROIC of 6.9% below its WACC. Consequently, the company tightened its full-year 2025 adjusted EPS outlook to approximately $4.00, a reduction from the prior $4.00-$4.75 range, citing a weaker Q3 despite expected Q4 improvements in crush and biodiesel margins. While most segments underperformed, the Nutrition segment achieved 5% growth, and ADM is pursuing a 'self-help' strategy focused on cost savings and capital discipline to navigate the broader market pressures.

Analysis

Archer-Daniels-Midland's (ADM) second-quarter 2025 results reveal significant operational and financial pressure, with a 10% year-over-year decline in both adjusted EPS to $0.93 and total segment operating profit to $830 million. The first-half performance was even weaker, with adjusted EPS down 35%, reflecting deep-seated challenges. A key concern is the company's profitability, as its trailing four-quarter adjusted return on invested capital (ROIC) of 6.9% now stands below its weighted average cost of capital (WACC) of 8.3%, indicating the firm is not currently generating economic value for shareholders. The weakness is concentrated in its largest unit, Ag Services & Oilseeds, where operating profit fell 17%, driven by a severe 75% drop in the Crushing sub-segment. In contrast, the Nutrition segment provided a bright spot, with revenue and operating profits growing approximately 5%, underscoring the benefits of its diversification and turnaround efforts. In response, management has tightened its full-year 2025 adjusted EPS outlook to approximately $4.00 from a prior range of $4.00-$4.75, signaling a weaker-than-expected third quarter. While ADM is actively pursuing a 'self-help' strategy with a target of $200-300 million in cost savings and maintaining capital discipline through dividend payments and a 2.1x leverage ratio, the revised guidance suggests these measures may not be enough to fully offset market headwinds in the near term.

Key Decisions for Investors

• Investors should closely monitor leading indicators for crush and biodiesel margins, as the company's ability to meet its tightened annual guidance hinges on a significant fourth-quarter recovery in these areas.
• Given that ADM's return on invested capital is currently below its cost of capital, it is prudent to scrutinize the effectiveness of management's cost-saving and network optimization initiatives for tangible evidence of improved value creation before increasing exposure.
• The sustained growth in the Nutrition segment contrasts sharply with declines elsewhere; consider this segment's performance a key gauge of the company's strategic pivot and a potential source of relative stability within the portfolio.
• While the consistent dividend provides income, the downward revision in earnings guidance and broad segment weakness suggest a cautious stance is warranted, as capital returns could be overshadowed by further share price erosion if operational performance does not stabilize.